Clinical Trial Update: A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. [Phase 3]

View source ↗

Summary

Phase 3 trial update of fosmanogepix for treating candidemia and invasive candidiasis in adults; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• fosmanogepix (fosmanogepix)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Candidemia, Candidiasis, Invasive | Phase 3 | Status: RECRUITING